Endometric factor of endometriosis-associated infertility
DOI:
https://doi.org/10.37800/RM2020-1-22Keywords:
endometriosis, infertility, endometrial receptivity, implantation, progesterone resistance, dydrogesteroneAbstract
BACKGROUND
Despite numerous studies and a not decreasing amount of endometriosis and associated infertility, the study of endometriosisassociated infertility does not lose its relevance, and the characteristics of the endometrium is appeared to be central and predictive factors that determine the success of overcoming infertility.
OBJECTIVE.
To reflect the molecular genetic features of the state of the endometrium with endometriosis associated with infertility,
expand the understanding of its pathogenesis, substantiate theoretical aspects of the use of hormonal preimplantation preparation of the endometrium in endometriosis-associated infertility.
MATERIALS AND METHODS.
To write this review, we searched for domestic and foreign publications in Russian and international search systems
(eLIBRARY, PubMed, MedLine, Crossref, etc.) over the past 1–16 years.
RESULTS.
The model of changes in endometrial receptivity is examined the mechanisms of resistance to progesterone and overproduction of estrogens as key endometrial factors in the pathogenesis of endometriosis-associated infertility and theoretical justification for the use of hormonal therapy for the preimplantation preparation of compromised endometrium is given.
CONCLUSION.
Despite the large number of publications, there is no consensus and the same approaches to determining the receptivity
of the endometrium and its role in implantation disorders in endometriosis, as well as clear ideas about the pathogenesis of
endometriosis-associated infertility. A personalized approach in the management of patients with endometriosis-associated
infertility will lead to a common denominator of many factors affecting reproduction and determine their potential role in both
the diagnosis and treatment of a particular patient.
References
M.C. Inhorn, P. Patrizio. Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century. Hum Reprod Update. 2015; 21 (4): 411–426.
Vander Borght, M., Wyns C. Fertility and infertility: Definition and epidemiology. Clin Biochem. 2018; 62: 2-10.
Под ред. В.Е. Радзинского. Бесплодный брак: версии и контраверсии. Москва. М.: ГЭОТАР-Медиа. 2018. 404 с. / Pod red. V.E. Radzinskogo. Besplodnyj brak: versii i kontraversii. Moskva. M.: GEOTAR-Media. 2018. 404 s. [in Russian].
Шмидт А. А., Замятнин С. А., Гончар И. С., Коровин А. Е., Городнюк И. О., Коцур А. В. Эпидемиология бесплодия в России и за рубежом. Клиническая патофизиология. 2019; 1: 9-12. / Shmidt A. A., Zamyatnin S. A., Gonchar I. S., Korovin A. E., Gorodnyuk I. O., Kocur A. V. Epidemiologiya besplodiya v Rossii i za rubezhom. Klinicheskaya patofiziologiya. 2019; 1: 9-12. [in Russian].
Evans MB, Decherney AH. Fertility and endometriosis. Clin Obstet Gynecol. 2017; 60: 497–502.
Краснопольская К.В. Лечение бесплодия при эндометриозе: Взгляд репродуктолога. М., 2019; с. 28–80. / Krasnopol'skaia K.V. Lechenie besplodiia pri endometrioze: Vzgliad reproduktologa. Moscow, 2019; p. 28–80. [in Russian].
Оразов М.Р., Радзинский В.Е., Хамошина М.Б., Кавтеладзе Е.В., Пухальская И.Ф., Шустова В.Б., Читанава Ю.С. Эффективность лечения бесплодия, обусловленного рецидивирующим наружным генитальным эндометриозом. Гинекология. 2019; 21 (1): 38–43. / Orazov M.R., Radzinskij V.E., Hamoshina M.B., Kavteladze E.V., Puhal'skaya I.F., SHustova V.B., CHitanava YU.S. Effektivnost' lecheniya besplodiya, obuslovlennogo recidiviruyushchim naruzhnym genital'nym endometriozom. Ginekologiya. 2019; 21 (1): 38–43. [in Russ.].
Evans J, Salamonsen LA., Winship A, Menkhorst E, Nie G, Gargett CE, Dimitriadis E. Fertile ground: human endometrial programming and lessons in health and disease. Nature Reviews Endocrinology. 2016; 12(11): 654–667.
Шуршалина А.В., Демура Т.А. Морфофункциональные перестройки эндометрия в «окно имплантации». Акушерство и гинекология. 2011;7-2:9-13. / Shurshalina A.V., Demura T.A. Morfofunkcional'nye perestrojki endometriya v «okno implantacii». Akusherstvo i ginekologiya. 2011;7-2:9-13. [in Russian]
Под ред. Савельевой Г.М., Сухих Г.Т., Серова В.Н., Радзинского В.Е., Манухина И.Б. Национальное руководство по гинекологии. М.: ГЭОТАР-Медиа. 2017. / Pod red. Savel'evoj G.M., Suhih G.T., Serova V.N., Radzinskogo V.E., Manuhina I.B. Nacional'noe rukovodstvo po ginekologii. M.: GEOTAR-Media. 2017. [in Russ.]
Lessey BA. Implantation defects in infertile women with endometriosis. Annals of the New York Academy of Sciences. 2002; 955: 265–80.
Lessey BA, Lebovic DI, Taylor RN. Eutopic endometrium in women with endometriosis: ground zero for the study of implantation defects. Seminars in reproductive medicine. 2013; 31: 109–24.
Lessey BA, Young SL. Homeostasis imbalance in the endometrium of women with implantation defects: the role of estrogen and progesterone. Seminars in reproductive medicine. 2014; 32: 365–75.
Lessey BA, Kim JJ. Endometrial Receptivity in Eutopic Endometrium of Women with Endometriosis It is affected, let me show you why. Fertil Steril. 2017; 108(1): 19–27.
Brosens I, Brosens JJ, Benagiano G. The eutopic endometrium in endometriosis: are the changes of clinical significance? Reprod Biomed Online. 2012; 24(5): 496-502.
Пономаренко К.Ю. Рецептивность эндометрия у женщин с нарушениями в репродуктивной системе. Журнал акушерства и женских болезней. 2017; 66(4): 90–7. / Ponomarenko K.YU. Receptivnost' endometriya u zhenshchin s narusheniyami v reproduktivnoj sisteme. ZHurnal akusherstva i zhenskih boleznej. 2017; 66(4): 90–7. [in Russ.].
Парамонова Н.Б., Коган Е.А., Колотовкина А.В., Бурменская О.В. Морфологические и молекулярно-биологические признаки нарушения рецептивности эндометрия при бесплодии женщин, страдающих наружным генитальным эндометриозом. Архив патологии. 2018; 3: 11-18. / Paramonova N.B., Kogan E.A., Kolotovkina A.V., Burmenskaya O.V. Morfologicheskie i molekulyarno-biologicheskie priznaki narusheniya receptivnosti endometriya pri besplodii zhenshchin, stradayushchih naruzhnym genital'nym endometriozom. Arhiv patologii. 2018; 3: 11-18. [in Russ.].
Da Broi MG, Rocha CV Jr, Carvalho FM, Martins WP, Ferriani RA, Navarro PA. Ultrastructural Evaluation of Eutopic Endometrium of Infertile Women With and Without Endometriosis During the Window of Implantation: A Pilot Study. Reprod Sci. 2017; 24(10): 1469-75.
Usadi RS, Murray MJ, Bagnell RC, Fritz MA, Kowalik AI, Meyer WR, Lessey BA. Temporal and morphologic characteristics of pinopod expression across the secretory phase of the endometrial cycle in normally cycling women with proven fertility. Fertil Steril 2003; 79(4): 970–4.
Quinn CE, Casper RF. Pinopodes: a questionable role in endometrial receptivity. Hum Reprod Update. 2009; 15(2): 229-36.
Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Köntgen F, Abbondanzo SJ. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature. 1992; 359 (6390):76-9.
Cheng J, Rosario G, Cohen TV, Hu J, Stewart CL. Tissue-Specific Ablation of the LIF Receptor in the Murine Uterine Epithelium Results in Implantation Failure. Endocrinology. 2017; 158(6):1916-28.
Song H., Lim H. Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation. Reproduction. 2006; 131: 341–9.
Rosario G.X., Stewart C.L. The Multifaceted Actions of Leukaemia Inhibitory Factor in Mediating Uterine Receptivity and Embryo Implantation. Am. J. Reprod. Immunol. 2016; 75: 246–255.
Franasiak J.M., Holoch K.J., Yuan L., Schammel D.P., Young S.L., Lessey B.A. Prospective assessment of midsecretory endometrial leukemia inhibitor factor expression versus ανβ3 testing in women with unexplained infertility. Fertil Steril. 2014; 101(6):1724-31.
Schmitz CR, Oehninger S, Genro VK, Chandra N, Lattanzio F, Yu L, Cunha-Filho JS. Alterations in expression of endometrial milk fat globule-EGF factor 8 (MFG-E8) and leukemia inhibitory factor (LIF) in patients with infertility and endometriosis. JBRA Assist Reprod. 2017; 21(4):313-320.
Kim BG, Yoo JY, Kim TH, Shin JH, Langenheim JF, Ferguson SD. Aberrant activation of signal transducer and activator of transcription-3 (STAT3) signaling in endometriosis. Hum Reprod. 2015; 30(5): 1069-78.
Yoo JY, Jeong JW, Fazleabas AT, Tayade C, Young SL, Lessey BA. Protein Inhibitor of Activated STAT3 (PIAS3) Is Down-Regulated in Eutopic Endometrium of Women with Endometriosis. Biol Reprod. 2016; 95(1): 11.
Колотовкина А.В., Калинина Е.А., Коган Е.А. Морфофункциональные особенности эндометрия у больных эндометриоз-ассоциированным бесплодием (обзор литературы). Гинекология. 2012; 4: 9-14. / Kolotovkina A.V., Kalinina E.A., Kogan E.A. Morfofunkcional'nye osobennosti endometriya u bol'nyh endometrioz-associirovannym besplodiem (obzor literatury). Ginekologiya. 2012; 4: 9-14. [in Russ].
Lessey BA, Damjanovich L, Coutifaris C, Castelbaum A, Albelda SM, Buck CA. Integrin adhesion molecules in the human endometrium Correlation with the normal and abnormal menstrual cycle. The Journal of clinical investigation. 1992;90:188–95.
Lessey BA, Castelbaum AJ, Sawin SW, Buck CA, Schinnar R, Bilker W, Strom BL. Aberrant integrin expression in the endometrium of women with endometriosis. The Journal of clinical endocrinology and metabolism. 1994; 79:643–9.
Casals G, Ordi J, Creus M, Fábregues F, Carmona F, Casamitjana R, Balasch J. Expression pattern of osteopontin and αvβ3 integrin during the implantation window in infertile patients with early stages of endometriosis. Hum. Reprod. 2012; 27(3):805-813.
Demir M, Ince O, Ozkan B, Kelekci S, Sutcu R, Yilmaz B. Endometrial flushing αVβ3 integrin, glycodelin and PGF2α levels for evaluating endometrial receptivity in women with polycystic ovary syndrome, myoma uteri and endometrioma. Gynecol Endocrinol. 2017; 33(9): 716-20.
Аганезов С.С., Аганезова Н.В., Мороцкая А.В., Пономаренко К.Ю. Рецептивность эндометрия у женщин с нарушениями репродуктивной функции. Журнал акушерства и женских болезней. 2017; 66(3): 135–42. / Aganezov S.S., Aganezova N.V., Morockaya A.V., Ponomarenko K.YU. Receptivnost' endometriya u zhenshchin s narusheniyami reproduktivnoj funkcii. ZHurnal akusherstva i zhenskih boleznej. 2017; 66(3): 135–42. [in Russian]
Focarelli R, Luddi A, De Leo V, Capaldo A, Stendardi A, Pavone V, Benincasa L, Belmonte G, Petraglia F, Piomboni P. Dysregulation of GdA Expression in Endometrium of Women With Endometriosis: Implication for Endometrial Receptivity. Reprod Sci. 2018; 25(4):579-86.
Mirkin S, Arslan M, Churikov D, Corica A, Diaz JI, Williams S, Bocca S, Oehninger S. In search of candidate genes critically expressed in the human endometrium during the window of implantation. Hum Reprod. 2005;20: 2104–7.
Schmitz C, Yu L, Bocca S, Anderson S, Cunha-Filho JS, Rhavi BS, Oehninger S. Role for the endometrial epithelial protein MFG-E8 and its receptor integrin αvβ3 in human implantation: results of an in vitro trophoblast attachment study using established human cell lines. Fertil Steril. 2014;101: 874–882.
Franchi A, Bocca S, Anderson S, Riggs R, Oehninger S. Expression of milk fat globule EGF-factor 8 (MFG-E8) mRNA and protein in the human endometrium and its regulation by prolactin. Mol Hum Reprod. 2011; 17(6): 360-71.
Du H, Taylor HS. The Role of Hox Genes in Female Reproductive Tract Development, Adult Function, and Fertility. Cold Spring Harb Perspect Med. 2015;6(1): a023002.
Özcan C, Özdamar Ö, Gökbayrak ME, Doğer E, Çakıroğlu Y, Çine N. HOXA-10 gene expression in ectopic and eutopic endometrium tissues: Does it differ between fertile and infertile women with endometriosis? Eur. J. Obstet. Gynecol. Reprod. Biol. 2019; 233: 43-8.
Celik O, Unlu C, Otlu B, Celik N, Caliskan E. Laparoscopic endometrioma resection increases peri-implantation endometrial HOXA-10 and HOXA-11 mRNA expression. Fertil Steril. 2015; 104(2): 356-365.
Patel BG, Rudnicki M, Yu J, Shu Y, Taylor RN. Progesterone resistance in endometriosis: origins, consequences and interventions. Acta Obstet Gynecol Scand.2017; 96(6): 623-632.
Patel B., Elguero S., Thakore S., Dahoud W., Bedaiwy M., Mesiano S. Role of nuclear progesterone receptor isoforms in uterine pathophysiology. Hum. Reprod. Update. 2015; 21: 155–173.
Ryan M. Marquardt, Tae Hoon Kim, Jung-Ho Shin, Jae-Wook Jeong. Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis? Int J Mol Sci. 2019; 20(15): 3822.
Wu SP, Li R, DeMayo FJ. Progesterone Receptor Regulation of Uterine Adaptation for Pregnancy. Progesterone Receptor Regulation of Uterine Adaptation for Pregnancy. Trends Endocrinol Metab. 2018; 29(7): 481-91.
Vasquez YM, Wang X, Wetendorf M, Franco HL, Mo Q, Wang T. FOXO1 regulates uterine epithelial integrity and progesterone receptor expression critical for embryo implantation. PLoS Genet. 2018;14(11): e1007787.
Yang H., Zhou Y., Edelshain B., Schatz F., Lockwood C.J., Taylor H.S. FKBP4 is regulated by HOXA10 during decidualization and in endometriosis. Reproduction. 2012; 143: 531–538.
Tranguch S., Cheung-Flynn J., Daikoku T., Prapapanich V., Cox M.B., Xie H., Wang H., Das S.K., Smith D.F., Dey S.K. Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation. Proc. Natl. Acad. Sci. USA. 2005; 102: 14326–31.
Rubel CA, Wu SP, Lin L, Wang T, Lanz RB, Li X. A Gata2-Dependent Transcription Network Regulates Uterine Progesterone Responsiveness and Endometrial Function. Cell Rep. 2016; 17(5): 1414-25.
Wang X, Li X, Wang T, Wu SP, Jeong JW, Kim TH, Young SL, Lessey BA, Lanz RB, Lydon JP, DeMayo FJ. SOX17 regulates uterine epithelial-stromal cross-talk acting via a distal enhancer upstream of Ihh. Nat. Commun. 2018; 9:4421.
Wölfler MM, Küppers M, Rath W, Buck VU, Meinhold-Heerlein I, Classen-Linke I. Altered expression of progesterone receptor isoforms A and B in human eutopic endometrium in endometriosis patients. Ann Anat. 2016; 206: 1-6.
Moberg C., Bourlev V., Ilyasova N., Olovsson M. Levels of oestrogen receptor, progesterone receptor and alphaB-crystallin in eutopic endometrium in relation to pregnancy in women with endometriosis. Hum. Fertil. (Camb.) 2015; 18:30–7.
Su R.W., Strug M.R., Joshi N.R., Jeong J.W., Miele L., Lessey B.A., Young S.L., Fazleabas A.T. Decreased Notch pathway signaling in the endometrium of women with endometriosis impairs decidualization. J. Clin. Endocrinol. Metab.2015; 100:E433–E442.
Dyson MT, Roqueiro D, Monsivais D, Ercan CM, Pavone ME, Brooks DC, Kakinuma T, Ono M, Jafari N, Dai Y, Bulun SE. Genome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis. PLoS Genet. 2014; 10: e1004158.
Osiński M, Wirstlein P, Wender-Ożegowska E, Mikołajczyk M, Jagodziński PP, Szczepańska M. HSD3B2, HSD17B1, HSD17B2, ESR1, ESR2 and AR expression in infertile women with endometriosis. Ginekol Pol. 2018; 89(3): 125-34.
Bulun SE, Yilmaz BD, Sison C, Miyazaki K, Bernardi L, Liu S, Kohlmeier A, Yin P, Milad M, Wei J. Endometriosis. Endocr Rev. 2019; 40(4): 1048-79.
Bulun SE. Endometriosis. N Engl J Med. 2009; 360(3): 268–79.
Bernardi LA, Dyson MT, Tokunaga H, Sison C, Oral M, Robins JC, Bulun SE. The Essential Role of GATA6 in the Activation of Estrogen Synthesis in Endometriosis. Reprod Sci. 2019; 26(1): 60-9.
Serdar E. Bulun, Diana Monsivais, Toshiyuki Kakinuma, Yuichi Furukawa, Lia Bernardi, Mary Ellen Pavone, Matthew Dyson. Molecular Biology of Endometriosis: From Aromatase to Genomic Abnormalities. Semin Reprod Med 2015; 33(03): 220-224
Izawa M, Taniguchi F, Harada T. GATA6 expression promoted by an active enhancer may become a molecular marker in endometriosis lesions. Am J Reprod Immunol. 2019; 81(2): e13078.
Оразов М.Р., Радзинский В.Е., Хамошина М.Б., Кавтеладзе Е.В., Шустова В.Б., Цораева Ю.Р., Новгинов Д.С. Бесплодие, ассоциированное c эндометриозом: от легенды к суровой реальности. Трудный пациент. 2019: 1–2(17):6-12. / Orazov M.R., Radzinskij V.E., Hamoshina M.B., Kavteladze E.V., SHustova V.B., Coraeva YU.R., Novginov D.S. Besplodie, associirovannoe c endometriozom: ot legendy k surovoj real'nosti. Trudnyj pacient. 2019: 1–2(17): 6-12. [in Russian].
Торшин И.Ю., Громова О.А., Сухих Г.Т., Галицкая С.А., Юргель И.С. Молекулярные механизмы дидрогестерона (Дюфастон®). Полногеномное исследование транскрипционных эффектов рецепторов прогестерона, андрогенов и эстрогенов. Гинекология. 2009; 05: 9-15. / Torshin I.YU., Gromova O.A., Suhih G.T., Galickaya S.A., YUrgel I.S. Molekulyarnye mekhanizmy didrogesterona (Dyufaston®). Polnogenomnoe issledovanie transkripcionnyh effektov receptorov progesterona, androgenov i estrogenov. Ginekologiya. 2009; 05: 9-15. [in Russ.].
Linden M. van der, Buckingham, K., Farquhar, C., Kremer, J.A., and Metwally, M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst. Rev. 2015: CD009154.
Griesinger G, Tournaye H, Macklon N, Petraglia F, Arck P, Blockeel C, van Amsterdam P, Pexman-Fieth C, Fauser BC. Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction. Reprod Biomed Online. 2019; 38(2): 249-259.
Pallacks C, Hirchenhain J, Krüssel JS, Fehm TN, Fehr D. Endometriosis doubles odds for miscarriage in patients undergoing IVF or ICSI. European Journal of Obstetric, Gynecology, and Reproductive Biology. 2017; 213: 33-38.
Коллектив авторов. Резолюция совещания экспертов на тему «Возможности персонализации гормональной терапии эндометриоза с использованием препарата дидрогестерон. Утверждение протокола многоцентрового открытого наблюдательного исследования по применению дидрогестерона для лечения эндометриоза в России (исследование «ОРХИДЕЯ»)». Проблемы репродукции. 2018; 5: 41-44. / Kollektiv avtorov. Rezolyuciya soveshchaniya ekspertov na temu «Vozmozhnosti personalizacii gormonal'noj terapii endometrioza s ispol'zovaniem preparata didrogesteron. Utverzhdenie protokola mnogocentrovogo otkrytogo nablyudatel'nogo issledovaniya po primeneniyu didrogesterona dlya lecheniya endometrioza v Rossii (issledovanie «ORHIDEYA»)». Problemy reprodukcii. 2018; 5: 41-44. [in Russ.].
Камлюк А.А. Опыт гестагенной поддержки сочетанием препаратов в циклах ЭКО. Репродуктивное здоровье. Восточная Европа. 2012; 4 (22): 143-149. / Kamlyuk A.A. Opyt gestagennoj podderzhki sochetaniem preparatov v ciklah EKO. Reproduktivnoe zdorov'e. Vostochnaya Evropa. 2012; 4 (22): 143-149. [in Russ.].
Additional Files
Published
How to Cite
Issue
Section
License
The articles published in this Journal are licensed under the CC BY-NC-ND 4.0 (Creative Commons Attribution – Non-Commercial – No Derivatives 4.0 International) license, which provides for their non-commercial use only. Under this license, users have the right to copy and distribute the material in copyright but are not permitted to modify or use it for commercial purposes. Full details on the licensing are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.
